CMMB - CIK 0001534248
Chemomab Therapeutics Ltd. has filed 347 documents with the SEC between 2011 and 2026. The most frequent type is 6-k (60 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2021-10-26 | 2021-10-26 |
| Major company event | 8-K | 2021-10-25 | 2021-10-25 |
| Proxy statement | DEF 14A | 2021-09-17 | 2021-09-17 |
| Employee stock plan | S-8 | 2021-09-13 | - |
| PRE 14A | - | 2021-09-03 | 2021-09-03 |
| Major company event | 8-K | 2021-09-02 | 2021-09-02 |
| Quarterly report | 10-Q | 2021-08-13 | 2021-06-30 |
| Major company event | 8-K | 2021-08-13 | 2021-08-13 |
| Major company event | 8-K | 2021-07-22 | 2021-07-22 |
| Proxy statement | DEF 14A | 2021-06-14 | 2021-06-14 |
| PRE 14A | - | 2021-06-01 | 2021-06-01 |
| EFFECT | - | 2021-05-17 | - |
| Major company event | 8-K | 2021-05-13 | 2021-05-13 |
| Quarterly report | 10-Q | 2021-05-13 | 2021-03-31 |
| Company correspondence | CORRESP | 2021-05-12 | - |
| Insider trade | 4 | 2021-05-10 | 2021-05-07 |
| SEC correspondence | UPLOAD | 2021-05-05 | - |
| Securities registration | S-3 | 2021-04-30 | - |
| 424B3 | - | 2021-04-29 | - |
| EFFECT | - | 2021-04-28 | - |
| Company correspondence | CORRESP | 2021-04-26 | - |
| SEC correspondence | UPLOAD | 2021-04-23 | - |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Insider trade | 4 | 2021-04-21 | 2021-04-19 |
| Activist ownership stake (update) | SC 13D/A | 2021-04-15 | - |
| Securities registration | S-3 | 2021-04-15 | - |
| Major company event (amended) | 8-K/A | 2021-04-14 | 2021-03-15 |
| Major company event | 8-K | 2021-04-05 | 2021-04-05 |
| D | - | 2021-03-30 | - |
| Insider trade | 4 | 2021-03-26 | 2021-03-16 |
| Passive ownership stake | SC 13G | 2021-03-26 | - |
| Activist ownership stake | SC 13D | 2021-03-26 | - |
| New insider ownership | 3 | 2021-03-26 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-25 | 2021-03-16 |
| Major company event (amended) | 8-K/A | 2021-03-19 | 2021-03-15 |
| Insider trade | 4 | 2021-03-18 | 2021-03-16 |
| New insider ownership | 3 | 2021-03-18 | 2021-03-16 |
| Insider trade | 4 | 2021-03-18 | 2021-03-16 |
| Major company event | 8-K | 2021-03-17 | 2021-03-15 |